IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$39.99
+0.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 69.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.22x
- Price / sales
- 16.48x
- Price / cash flow
- -20.65x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 13.07x
- EV / EBITDA
- -14.40x
- EV / EBIT
- -14.10x
- Market cap
- $3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026